| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 14.337 | 47.395 | 61.846 | 59.954 | 48.284 | 58.277 | - |
| Total Income - EUR | - | - | 0 | 14.355 | 47.411 | 69.224 | 61.643 | 48.965 | 58.436 | - |
| Total Expenses - EUR | - | - | 42 | 12.379 | 32.947 | 27.766 | 25.220 | 39.852 | 44.217 | - |
| Gross Profit/Loss - EUR | - | - | -42 | 1.976 | 14.465 | 41.458 | 36.423 | 9.113 | 14.219 | - |
| Net Profit/Loss - EUR | - | - | -42 | 1.836 | 13.991 | 40.839 | 35.822 | 8.626 | 13.634 | - |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 2 | - |
Check the financial reports for the company - Vetrolara Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 12.797 | 12.513 | 12.099 | 59.402 | - |
| Current Assets | - | - | 44 | 6.430 | 19.938 | 45.970 | 75.138 | 87.252 | 88.171 | - |
| Inventories | - | - | 0 | 6.136 | 3.349 | 8.741 | 11.314 | 7.995 | 10.156 | - |
| Receivables | - | - | 0 | 0 | 438 | 1.273 | 841 | 818 | 1.066 | - |
| Cash | - | - | 44 | 294 | 16.151 | 35.956 | 62.984 | 78.439 | 76.949 | - |
| Shareholders Funds | - | - | 1 | 1.837 | 15.792 | 56.331 | 86.647 | 95.542 | 108.887 | - |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | 42 | 4.669 | 4.196 | 2.514 | 1.551 | 3.867 | 38.704 | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Vetrolara Medical Srl